The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta
Data up to Jan 2025
Total Citations Per Year
Abstract
References (34)
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
1987 • 4,980 citations
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
1987 • 3,281 citations
Physical growth: National Center for Health Statistics percentiles
1979 • 2,426 citations
Genetic heterogeneity in osteogenesis imperfecta.
1979 • 2,147 citations
New approaches for interpreting projected bone densitometry data
1992 • 1,042 citations
Bisphosphonates: Mechanisms of Action
1998 • 1,029 citations
Cyclic Administration of Pamidronate in Children with Severe Osteogenesis Imperfecta
1998 • 1,007 citations
Alendronate for the Treatment of Osteoporosis in Men
2000 • 987 citations
Skeletal structural adaptations to mechanical usage (SATMU): 1. Redefining Wolff's Law: The bone modeling problem
1990 • 938 citations
Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density
2002 • 885 citations
Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes.
1993 • 685 citations
Bone Microdamage and Skeletal Fragility in Osteoporotic and Stress Fractures
1997 • 675 citations
Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women
2000 • 586 citations
Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.
1997 • 527 citations
Type V Osteogenesis Imperfecta: A New Form of Brittle Bone Disease
2000 • 503 citations
Osteogenesis Imperfecta Type VI: A Form of Brittle Bone Disease with a Mineralization Defect
2002 • 428 citations
Targeted and nontargeted remodeling
2002 • 403 citations
Normative data for iliac bone histomorphometry in growing children
2000 • 325 citations
Static and dynamic bone histomorphometry in children with osteogenesis imperfecta
2000 • 317 citations
Bisphosphonates: Mechanisms of Action
1998 • 305 citations
Structural and cellular changes during bone growth in healthy children
2000 • 281 citations
Metabolic Bone Disease and Clinically Related Disorders
1998 • 280 citations
Pamidronate Treatment of Severe Osteogenesis Imperfecta in Children under 3 Years of Age*
2000 • 280 citations
Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta
2002 • 267 citations
Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease
2002 • 266 citations
Long-Term Effects of Intravenous Pamidronate in Fibrous Dysplasia of Bone
1997 • 264 citations
Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis
2001 • 191 citations
Analysis of the COL1A1 and COL1A2 Genes by PCR Amplification and Scanning by Conformation-Sensitive Gel Electrophoresis Identifies Only COL1A1 Mutations in 15 Patients with Osteogenesis Imperfecta Type I: Identification of Common Sequences of Null-Allele Mutations
1998 • 175 citations
Pamidronate Treatment of Severe Osteogenesis Imperfecta in Children under 3 Years of Age
2000 • 135 citations
Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides
1994 • 128 citations
Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: A comparative histomorphometric study on the cancellous bone formed before, during, and after treatment
1997 • 113 citations
Effects of Alendronate on Bone Quality and Remodeling in Glucocorticoid-Induced Osteoporosis: A Histomorphometric Analysis of Transiliac Biopsies
2000 • 106 citations
Quantitative analysis of trabecular morphogenesis in the human costochondral junction during the postnatal period in normal subjects
1997 • 48 citations
Bone Histomorphometric Evaluation of Pamidronate Treatment in Clinically Manifest Osteoporosis
1999 • 42 citations